Edit |   |
---|---|
Antigenic Specificity | CD180 (RP105), Mouse |
Clone | RP/14 |
Host Species | Rat |
Reactive Species | mouse |
Isotype | IgG2aκ |
Format | purified |
Size | 500 µg in 0.5 mL |
Concentration | n/a |
Applications | Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD180 (RP105) Antibody, anti-mouse, pure-functional grade. Clone RP/14 recognizes CD180, a type I transmembrane protein structurally similar to Toll like receptors (TLRs), with the conserved features of TLRs, including a leucine-rich repeat extracellular domain and regions containing conserved cysteines. However, in contrast to TLRs, CD180 lacks a typical TIR domain, containing only 6 to 11 intracytoplasmic amino acids. Antibody mediated ligation of CD180 was shown to induce B cell proliferation and protection from subsequent radiation- or dexamethasone-induced apoptosis. Expression of CD180 is found on mature B cells, monocytes, macrophages, and dendritic cells. CD180 activity is dependent on physical association with a molecule called MD-1. In B cells, CD180, together with TLR4, has been shown to induce B cell proliferation in response to LPS. However, in primary myeloid cells and in vivo, CD180 acts as an inhibitor of TLR4 signaling. |
Immunogen | n/a |
Other Names | Ly78, RP105 |
Gene, Accession # | n/a |
Catalog # | 130-101-182 |
Price | $400 |
Order / More Info | CD180 (RP105), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Divanovic, S. et al. (2007) Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105. J. Leukoc. Biol. 82: 265-271. | Divanovic, S. et al. (2005) Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J. Endotoxin Res. 11: 363-368. |